Skip to main content

The Impact of Pharmacologic Therapy on the Costs of Asthma

Buy Article:

$36.50 + tax (Refund Policy)

Continued growth of health care as a major sector of the U.S. economy has brought concern about whether health care services can be made more efficient and effective. Much of this concern is global in nature, relating to comprehensive issues in preventive and therapeutic services. Yet, examination of specific conditions provides insight into explicit approaches to achieving more effective care. The purpose of this report is to provide an overview of one health condition, asthma, and will 1) introduce the health economic concepts that define the costs of illness for asthma; 2) discuss the outcomes that are relevant to effective asthma management from a health systems perspective; 3) review the concepts underlying the study of cost-effectiveness of asthma care; and 4) examine the existing and emerging literature on the cost-effectiveness of asthma care.

Document Type: Research Article

Publication date: 01 July 1994

More about this publication?
  • Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.

    The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma and by having the potential to directly impact the quality of patient care. AAP welcomes the submission of original works including peer-reviewed original research and clinical trial results. Additionally, as the official journal of the Eastern Allergy Conference (EAC), AAP will publish content from EAC poster sessions as well as review articles derived from EAC lectures.

    Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.

    Articles marked "F" offer free full text for personal noncommercial use only.

    The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Information for Advertisers
  • Reprint Requests
  • Commercial level: Permission to use content
  • www.JFoodAllergy.com
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content